Caretrust Reit’s Earnings Call Contradictions: Portfolio Strategy Shifts, SHOP Acquisition Discrepancies Clash

<<>>

Date of Call: Aug 7, 2026

Financials Results

• Revenue: Record revenues, up significantly YOY (specific figure not provided)
• EPS: Not explicitly provided; normalized FFO per share $0.51, up approximately 19% YOY
• Gross Margin: Not explicitly provided
• Operating Margin: Not explicitly provided

Guidance:

• Normalized FFO per share projected at $2.03 to $2.06 for full year 2026.
• Normalized FAD per share projected at $2.01 to $2.04 for full year 2026.
• Represents growth of approximately 16.1% in normalized FAD per share and 15.25% in normalized FFO per share compared to prior year.

Business Commentary:

Record Investment Activity:

• CareTrust reported closing on approximately $900 million in investments during Q2, with an additional $308 million closed after quarter-end, at a blended stabilized yield of 8.9% and 7.8%, respectively.
• This growth was driven by strong performance across its platforms, including U.S. skilled nursing, U.K. care homes, loans, and shop portfolios.

Financial Performance and Guidance:

• The company's normalized FFO increased by 40% and normalized FAD increased by 43% year-on-year, with per share values rising to $0.51.
• This strong financial performance was supported by increased investment activity and strategic equity issuances.

Operator and Market Relationships:

• CareTrust highlighted that its operators outperform industry averages in star ratings, health inspections, and quality care measures.
• The company attributes its success to long-term partnerships with high-quality operators and a focus on sustainable growth.

Pipeline and Growth Strategy:

• The investment pipeline stands at approximately $540 million, with a healthy mix of skilled nursing and loans to strategic operators.
• CareTrust's strategy is underpinned by disciplined underwriting, durable partnerships, and a focus on long-term value creation.

UK Market Expansion:

• A significant 16-property UK care home portfolio was acquired, representing a major investment in the U.K. market.
• This expansion is seen as a launching point to grow the relationship with the operator and leverage the scale and stability of the CareTrust platform.

Sentiment Analysis:

Overall Tone: Positive

• Management expressed strong optimism: "We are again on pace to deliver in a big way...", "last quarter was the single largest investment quarter...", "deal flow continues to be active and interesting...", "We're super bullish on the CareTrust story and not just what we've achieved, but where we are headed."

Q&A:

• Question from John (Wells Fargo): Could you talk more about building out the shop pipeline and the cadence?
  Response: Timing is uncertain, but relationship-building with operators creates a ready pipeline for quick action when the right off-market deals arise.

• Question from John (Wells Fargo): Can you talk about portfolio deals outside the quoted pipeline?
  Response: A few larger shop, SNF, and UK portfolios are being reviewed, but none are yet attractive enough to pursue.

• Question from Austin Worshmed (KeyBank Capital Markets): How does the new UK care home deal impact future pricing and potential scaling?
  Response: Scale commanded a slight premium, but the deal is viewed as a launching pad to grow with the operator in the future.

• Question from Robin Handel (BMO Capital Markets): How do you balance geographic diversification with partnering with top-quality operators?
  Response: Operator quality is paramount; the company prefers an A operator in a B market over a B operator in an A market and is comfortable with some concentration.

• Question from Robin Handel (BMO Capital Markets): What's the status of PACS discussions?
  Response: PACS is back to normal operations, and the company is open to doing deals with them again if the opportunity arises.

• Question from Michael Goldsmith (UBS): Can you provide more color on 'widening the aperture' in the UK?
  Response: It means sourcing more deals beyond traditional marketed deals, using operator relationships to bring in new deal flow and consider different structures like shop.

• Question from Michael Goldsmith (UBS): How do you balance discipline and opportunity in the shop market?
  Response: The team picks its spots on attractive IRRs, stretches to get deals when confident, but does not feel compelled to do suboptimal deals. SNF and UK care home opportunities fill the capital needs.

• Question from Michael Carroll (RBC Capital Markets): Have you seen cap rates compress in healthcare real estate?
  Response: Competition is increasing, especially in shop, but cap rates have not been dramatically impacted. The key is off-market sourcing through relationships.

• Question from Michael Carroll (RBC Capital Markets): What's the status of purchase options?
  Response: Most options are expected to expire unexercised, but the company maintains collaborative discussions with tenants for future deals.

• Question from Pharrell Granath (Bank of America): What is the composition of financing receivables?
  Response: They are almost entirely skilled nursing sale-leaseback opportunities with long-term purchase options, viewed in substance as owned triple-net assets.

• Question from Pharrell Granath (Bank of America): How are you thinking about cost of capital and Fed policy?
  Response: Low leverage provides optionality; the company is evaluating the full capital toolkit, including equity, and will be opportunistic based on macro conditions.

• Question from Hunter Fitzgerald: Why is CareTrust slower on shop deals compared to peers?
  Response: The company prefers being opportunistic across all three growth engines rather than feeling pressured to execute a shop-heavy strategy, and sometimes shop pricing doesn't meet risk-adjusted return thresholds.

• Question from Hunter Fitzgerald: What's the draw to skilled nursing as an industry?
  Response: Deep historical relationship, vital role in healthcare, strong demographics, and the ability to identify high-quality operators for superior risk-adjusted returns.

• Question from Alex: Are there any large portfolio initiatives or lease changes underway with SNF operators?
  Response: There is always some portfolio-level scrutiny, but nothing currently underway that would impact guidance or results.

• Question from Addie Rogers (Raymond James): Are you seeing any shift in risk or asset mix within skilled nursing?
  Response: The environment is currently stable from a regulatory and reimbursement standpoint, making it comfortable to continue acquiring.

• Question from Addie Rogers (Raymond James): What was the small loan-to-own asset, and is it instructive?
  Response: It was a UK transaction structured to facilitate closing while licensure was pending; it converted to real estate once licensure was obtained.

• Question from Michael: What's the strategic rationale for the loans in the pipeline?
  Response: Loans are either done alongside or in anticipation of future real estate acquisitions, serving as a virtuous cycle to unlock door to growth.

• Question from Michael: What's the yield and timeframe for the recent loan-to-own deal?
  Response: The assets are stable with low double-digit IRR potential, and margin expansion is expected from low 30s to high 30s over the next 2-3 years.

• Question from Jody (Mizuho): What's the potential for rent resets over time?
  Response: Rent coverage is very strong; the first opportunity to reset rents to market rates is in 2031, a few years off.

Contradiction Point 1

Nature and Sourcing of Large Portfolio Opportunities

It involves a direct contradiction on the company's strategy regarding large portfolio deals, shifting from excluding them due to low probability to actively pursuing them.

John (Wells Fargo) - John (Wells Fargo)

2026Q2: The company will pursue [portfolios that meet its attractiveness criteria]. - James(Chief Investment Officer)

Can you discuss the strategy for building the shop pipeline and timing discipline, the cadence of translating volumes, and portfolio deals outside the quoted pipeline, including SNF opportunities? - Farrell Granath (Bank of America)

2026Q1: The pipeline quote excludes larger portfolios due to their lower probability of closing, as they may be 'fishing expeditions' by sellers. - Dave Sedgwick(CEO)

Contradiction Point 2

Strategy and Performance Outlook for Skilled Nursing Facilities (SNF)

Contradiction on the strategic importance and growth expectations for the SNF segment.

Hunter Fitzgerald - Hunter Fitzgerald

2026Q2: Skilled nursing is vital to the healthcare continuum and will remain important... The risk-adjusted returns in skilled nursing are attractive. - Dave Sedgwick(CEO)

Why is CareTrust slower in shop acquisitions compared to peers despite having the best cost of capital, and is it due to pricing or competition? - Farrell Granath (Bank of America)

2026Q1: The SNF market is now predominantly off-market and relationship-driven, making deal flow more unpredictable. - James Callister(Chief Investment Officer)

Contradiction Point 3

SHOP Acquisition Pace and Strategy

Conflicting statements on whether the company is being disciplined or is slower due to a strategic focus elsewhere.

Hunter Fitzgerald - Hunter Fitzgerald

2026Q2: CareTrust has three growth engines and prefers to be opportunistic across all... CareTrust’s luxury is discipline—focusing on the best risk-adjusted returns, which often lie in SNF and UK care homes. - Dave Sedgwick(CEO)

Why is CareTrust slower in shop acquisitions compared to peers despite having the best cost of capital, and is it due to pricing or competition? - Michael Goldsmith (UBS Investment Bank)

2025Q4: The team is highly capable, but decisions on adding personnel depend on the specific deal circumstances... The team is now deeper and more capable, and the company has two new growth engines (U.K. care homes and SHOP). If meaningful, chunky opportunities materialize, CareTrust should be competitive and could have another substantial year. - Dave Sedgwick(CEO)

Contradiction Point 4

SHOP Market Competition and Pricing Impact

Mixed signals on whether competition has impacted pricing to the point of passing on deals.

Hunter Fitzgerald - Hunter Fitzgerald

2026Q2: It often comes down to pricing. When evaluating a deal, if the projected IRR or risk-adjusted return is insufficient given the pricing (e.g., mid-5% cap rates for stable assets), it is wiser to allocate capital elsewhere with better returns. - James(CIO)

Why is CareTrust slower in shop acquisitions compared to peers despite having the best cost of capital, and is this due to pricing or competition? - Michael Carroll (RBC Capital Markets)

2025Q4: SHOP is the most competitive segment due to heavy capital pursuit. CareTrust believes it can still find compelling deals that meet its IRR targets. - James Callister(CIO)

Contradiction Point 5

Senior Housing (SHOP) Acquisition Strategy and Pace

Strategy shifts from building a scalable infrastructure for smaller deals to waiting for larger, pipeline-attached opportunities.

Austin Worshmed (KeyBank Capital Markets) - Austin Worshmed (KeyBank Capital Markets)

2026Q2: The company will pursue any deal that makes sense, regardless of size, and look to expand relationships with operators, whether or not a predefined pipeline is attached. - David Sedgwick(CEO)

Regarding the large UK care home portfolio investment (16 properties), does this open the door to future deals with the operator and how much did scale impact pricing? - Michael Carroll (RBC)

20251107-2025 Q3: The company decided not to wait for a 'perfect' large portfolio deal. They built a scalable infrastructure for smaller shop deals first. - David Sedgwick(CEO)

<<>>